(Q35237319)

7 August 2017

1 reference

title

Chemical structures and biological activities of non-peptide selective kappa opioid ligands (English)

1 reference

7 August 2017

D. C. Rees

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1335584

15 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1335584

15 September 2022

publication date

1 January 1992

1 reference

Progress in medicinal chemistry

7 August 2017

published in

1 reference

7 August 2017

volume

29

1 reference

7 August 2017

page(s)

109-139

1 reference

Selective opioid receptor agonists and antagonists: research tools and potential therapeutic agents

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

Kappa-opioid receptors and analgesia

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

Molecular characterization of opioid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

[3H]U-69593 a highly selective ligand for the opioid kappa receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

Benzeneacetamide amines: structurally novel non-m.mu. opioids

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

Properties of a selective kappa agonist, U-50,488H

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

Compounds of novel structure having kappa-agonist behavioral effects in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

An opioid benzodiazepine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

Dynorphin1–8 and dynorphin1–9 are ligands for the κ-subtype of opiate receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

Kappa opioid binding sites in the dog cerebral cortex and spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

Characterization and visualization of rat and guinea pig brain kappa opioid receptors: evidence for kappa 1 and kappa 2 opioid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

Computer modeling of subtypes of kappa opioid receptors in adrenal medulla

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

Pharmacological profile of PD 117302, a selective kappa-opioid agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

Behavioral effects of a novel kappa opioid analgesic, U-50488, in rats and rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

Kappa receptor mediated opioid dependence in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

Psychotomimesis mediated by kappa opiate receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

Opiate antagonist improves neurologic recovery after spinal injury

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

Cardiovascular consequences of endogenous opiate antagonism

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

Protection from cerebral ischemia by U-50,488E, a specific kappa opioid analgesic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

Protection from ischemia-induced cerebral edema in the rat by U-50488H, a kappa opioid receptor agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

Beneficial effects of the kappa opioid receptor agonist U-50488H in experimental acute brain and spinal cord injury

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

PD117302, a selective non-peptide opioid kappa agonist, protects against NMDA and maximal electroshock convulsions in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

The anticonvulsant action of CI-977, a selective kappa-opioid receptor agonist: a possible involvement of the glycine/NMDA receptor complex

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

Kappa opioid receptor activation depresses excitatory synaptic input to rat locus coeruleus neurons in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

Correlation of ontogeny with function of [3H]U69593 labelled kappa opioid binding sites in the rat spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

Conformational characteristics of opioid kappa-receptor agonist: crystal structure of (5S,7S,8S)-(-)-N-methyl-N-[7-(1-pyrrolidinyl)-1- oxaspiro[4.5]dec-8-yl]benzeneacetamide (U69,593), and conformational comparison with some kappa-agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

Highly selective kappa opioid analgesics. Synthesis and structure-activity relationships of novel N-[(2-aminocyclohexyl)aryl]acetamide and N-[(2-aminocyclohexyl)aryloxy]acetamide derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

PD117302: a selective agonist for the kappa-opioid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

An in vitro profile of activity for the (+) and (-) enantiomers of spiradoline and PD117302.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

Selective and enantiospecific acylation of kappa opioid receptors by (1S,2S)-trans-2-isothiocyanato-N-methyl-N-[2-(1-pyrrolidinyl) cyclohexy l] benzeneacetamide. Demonstration of kappa receptor heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

Highly selective kappa-opioid analgesics. 2. Synthesis and structure-activity relationships of novel N-[(2-aminocyclohexyl)aryl]acetamide derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

Highly selective .kappa. opioid analgesics. 4. Synthesis of some conformationally restricted naphthalene derivatives with high receptor affinity and selectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

Highly selective kappa-opioid analgesics. 3. Synthesis and structure-activity relationships of novel N-[2-(1-pyrrolidinyl)-4- or -5-substituted-cyclohexyl]arylacetamide derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

CI-977, a novel and selective agonist for the kappa-opioid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

Synthesis of (1',2'-trans)-3-phenyl-1-[2'-(N-pyrrolidinyl)cyclohexyl]pyrrolid -2-ones as kappa-selective opiates

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

A novel series of potent and selective agonists at the opioid kappa-receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

2-(3,4-Dichlorophenyl)-N-methyl-N-[2-(1-pyrrolidinyl)-1-substituted-ethyl]-acetamides: the use of conformational analysis in the development of a novel series of potent opioid .kappa. agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

(2S)-1-(Arylacetyl)-2-(aminomethyl)piperidine derivatives: novel, highly selective .kappa. opioid analgesics

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

A series of novel, highly potent and selective agonists for the kappa-opioid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

Reversal of the actions of morphine on mesocortical dopamine metabolism in the rat by the kappa agonist MR-2034: tentative mu-2 opioid control of mesocortical dopaminergic projections

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

Factors affecting binding of trans-N-[2-(methylamino)cyclohexyl]benzamides at the primary morphine receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

Alterations in the stereochemistry of the kappa-selective opioid agonist U50,488 result in high-affinity sigma ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

Synthesis and evaluation of N-substituted cis-N-methyl-2-(1-pyrrolidinyl)cyclohexylamines as high affinity sigma receptor ligands. Identification of a new class of highly potent and selective sigma receptor probes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

Rational design of 4-[(methylsulfonyl)amino]benzamides as class III antiarrhythmic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

Common stereospecificity of opioid and dopamine systems for N-butyrophenone prodine-like compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

Benzofuro[2,3-c]pyridin-6-ols: synthesis, affinity for opioid-receptor subtypes, and antinociceptive activity

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

Cholecystokinin-A receptor ligands based on the kappa-opioid agonist tifluadom

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

The binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

Nitrogen-bridged conformationally constrained etorphine analogues. Synthesis and biological evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

Binaltorphimine and nor-binaltorphimine, potent and selective kappa-opioid receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970006-7

7 January 2021

10.1016/S0079-6468(08)70006-7

Identifiers

DOI

0 references

1 reference